← Back
Data updated: Mar 10, 2026
RHODES PHARMS
ImmunologyInfectious DiseaseMetabolic
RHODES PHARMS is a generic drug manufacturer focused on Immunology, Infectious Disease, Metabolic. Key products include APTENSIO XR.
1988
Since
23
Drugs
-
Trials
717
Approved (2yr)
Key Drugs
Recent Activity
TAPENTADOL HYDROCHLORIDE 2026-02-10
SCOPOLAMINE 2026-02-09
Labeling
SCOPOLAMINE 2026-02-09
Labeling
SCOPOLAMINE 2026-02-09
Labeling
SCOPOLAMINE 2026-02-09
Labeling
SCOPOLAMINE 2026-02-09
Labeling
TAPENTADOL HYDROCHLORIDE 2026-01-27
TAPENTADOL HYDROCHLORIDE 2026-01-26
FENOFIBRATE 2026-01-21
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE 2026-01-21
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 20%
1 drugs
Infectious Disease 20%
1 drugs
Metabolic 20%
1 drugs
Cardiovascular 20%
1 drugs
Respiratory 20%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology, Metabolic
Johnson & Johnson big-pharma
Immunology, Infectious Disease, Cardiovascular, Metabolic
Sanofi big-pharma
Metabolic, Infectious Disease, Immunology, Respiratory
AstraZeneca big-pharma
Respiratory, Cardiovascular, Metabolic, Immunology
Novartis big-pharma
Cardiovascular, Immunology, Respiratory
Active (10)
Discontinued (12)
FENOFIBRATE OXYCODONE AND ACETAMINOPHEN HYDROCODONE BITARTRATE AND ACETAMINOPHEN OXYCODONE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE MORPHINE SULFATE ACETAMINOPHEN AND CODEINE PHOSPHATE DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE THEOPHYLLINE FENOFIBRATE (MICRONIZED) DEXMETHYLPHENIDATE HYDROCHLORIDE BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
Company Info
- First Approval
- 1988-02-10
- Latest
- 2025-12-22
- Applications
- 31